These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 29850575)
1. Effects of Lidocaine-Mediated CPEB3 Upregulation in Human Hepatocellular Carcinoma Cell Proliferation In Vitro. Liu H; Wang Y; Chen B; Shen X; Li W Biomed Res Int; 2018; 2018():8403157. PubMed ID: 29850575 [TBL] [Abstract][Full Text] [Related]
2. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma. Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449 [TBL] [Abstract][Full Text] [Related]
3. Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis. Zhao L; Ma N; Liu G; Mao N; Chen F; Li J Dig Dis Sci; 2021 Dec; 66(12):4384-4397. PubMed ID: 33433806 [TBL] [Abstract][Full Text] [Related]
4. CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression. Zhang H; Zou C; Qiu Z; E F; Li Q; Chen M; Wang D; Tan Q; Yin W; Matunda C; Wang H; Zhang Y; Zhan C; Wang C; Wu Y; Xuan X; Wang Y; Zou C; Lv G; Gao X Cell Death Dis; 2020 Sep; 11(9):792. PubMed ID: 32968053 [TBL] [Abstract][Full Text] [Related]
5. Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo. Xing W; Chen DT; Pan JH; Chen YH; Yan Y; Li Q; Xue RF; Yuan YF; Zeng WA Anesthesiology; 2017 May; 126(5):868-881. PubMed ID: 28121635 [TBL] [Abstract][Full Text] [Related]
6. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP. Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208 [TBL] [Abstract][Full Text] [Related]
7. Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells. Le Gac G; Angenard G; Clément B; Laviolle B; Coulouarn C; Beloeil H Anesth Analg; 2017 Nov; 125(5):1600-1609. PubMed ID: 28857796 [TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression. Huang X; Ma J; Xu J; Su Q; Zhao J Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322 [TBL] [Abstract][Full Text] [Related]
10. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma. Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251 [TBL] [Abstract][Full Text] [Related]
12. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma. Li H; Fang L; Xiao X; Shen L Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1. Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma. Zou CD; Zhao WM; Wang XN; Li Q; Huang H; Cheng WP; Jin JF; Zhang H; Wu MJ; Tai S; Zou CX; Gao X Oncotarget; 2016 Jan; 7(1):266-78. PubMed ID: 26497556 [TBL] [Abstract][Full Text] [Related]
15. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo. Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192 [TBL] [Abstract][Full Text] [Related]
16. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Wang Z; Wei W; Sun CK; Chua MS; So S Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386 [TBL] [Abstract][Full Text] [Related]
17. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Yang N; Fu Y; Zhang H; Sima H; Zhu N; Yang G Oncotarget; 2015 Sep; 6(29):28151-63. PubMed ID: 26305675 [TBL] [Abstract][Full Text] [Related]
19. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G; Chen X; Chen S; Ye W; Hou K; Liang M J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of PPP5C inhibits growth of hepatocellular carcinoma cells in vitro. Feng L; Sun P; Li Z; Liu M; Sun S Appl Biochem Biotechnol; 2015 Jan; 175(1):526-34. PubMed ID: 25326185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]